Also categorized in BoardNews:
Cracker Barrel Holders Reject Biglari's Bid for Seat
x hide permanently

Selecta Biosciences Appoints Timothy C. Barabe to Board of Directors

Digital Journal

Selecta Biosciences, Inc. (NASDAQ:SELB), a clinical-stage biopharmaceutical company developing targeted antigen-specific immune therapies for rare and serious diseases, today announced the election of Timothy C. Barabe to the company’s Board of Directors ...

Mentions: CEO SEC Shareholders